These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8298824)

  • 1. Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic non-responders.
    Joffe RT; Levitt AJ; Bagby RM; MacDonald C; Singer W
    Br J Psychiatry; 1993 Nov; 163():574-8. PubMed ID: 8298824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression.
    Bschor T; Canata B; Müller-Oerlinghausen B; Bauer M
    J Affect Disord; 2001 May; 64(2-3):261-5. PubMed ID: 11313093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.
    Garbutt JC; Mayo JP; Gillette GM; Little KY; Mason GA
    Am J Psychiatry; 1986 Aug; 143(8):1038-9. PubMed ID: 3089033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT; Singer W; Levitt AJ; MacDonald C
    Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between antidepressant partial and nonresponse and subsequent response to antidepressant augmentation.
    Joffe RT; Levitt AJ
    J Affect Disord; 1999; 52(1-3):257-9. PubMed ID: 10357043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression?
    Gervasoni N; Aubry JM; Gex-Fabry M; Bertschy G; Bondolfi G
    Pharmacol Res; 2009 Mar; 59(3):202-6. PubMed ID: 19073260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
    Birkenhäger TK; Vegt M; Nolen WA
    Pharmacopsychiatry; 1997 Jan; 30(1):23-6. PubMed ID: 9065966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T3 and lithium potentiation of tricyclic antidepressants.
    Joffe RT
    Am J Psychiatry; 1988 Oct; 145(10):1317-8. PubMed ID: 3138921
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the duration for augmentation with T3 or lithium in resistant depression?
    Price LH
    J Clin Psychopharmacol; 1989 Feb; 9(1):73. PubMed ID: 2708563
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination therapies in antidepressive drug refractory depression--an overview].
    Schmauss M; Erfurth A
    Fortschr Neurol Psychiatr; 1996 Oct; 64(10):390-402. PubMed ID: 9036099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium and triiodothyronine augmentation of antidepressants.
    Joffe RT; Sokolov ST; Levitt AJ
    Can J Psychiatry; 2006 Oct; 51(12):791-3. PubMed ID: 17168254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis.
    Aronson R; Offman HJ; Joffe RT; Naylor CD
    Arch Gen Psychiatry; 1996 Sep; 53(9):842-8. PubMed ID: 8792761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
    Nierenberg AA; Fava M; Trivedi MH; Wisniewski SR; Thase ME; McGrath PJ; Alpert JE; Warden D; Luther JF; Niederehe G; Lebowitz B; Shores-Wilson K; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1519-30; quiz 1665. PubMed ID: 16946176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders.
    Dé Montigny C; Grunberg F; Mayer A; Deschenes JP
    Br J Psychiatry; 1981 Mar; 138():252-6. PubMed ID: 7272619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression.
    Schweitzer I; Tuckwell V
    Drug Saf; 1998 Dec; 19(6):455-64. PubMed ID: 9880089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appearance of mania in drug-resistant bipolar depressed patients after treatment with L-triiodothyronine.
    Evans DL; Strawn SK; Haggerty JJ; Garbutt JC; Burnett GB; Pedersen CA
    J Clin Psychiatry; 1986 Oct; 47(10):521-2. PubMed ID: 3759918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug combinations in the treatment of refractory depression: a review.
    Stern SL; Mendels J
    J Clin Psychiatry; 1981 Oct; 42(10):368-73. PubMed ID: 6116699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone potentiation of tricyclics.
    Extein IL; Gold MS
    Psychosomatics; 1988; 29(2):166-74. PubMed ID: 3130646
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of refractory primary depression].
    van Praag HM
    Ned Tijdschr Geneeskd; 1997 Jul; 141(28):1375-9. PubMed ID: 9380197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression.
    Price LH; Conwell Y; Nelson JC
    Am J Psychiatry; 1983 Mar; 140(3):318-22. PubMed ID: 6131612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.